mAb (BU63); Mouse anti Human CD86 Antibody; Flow; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab095464-10μg (Trial Size) Apply for free trial size（?） Every year, as a valued customer, you have the exclusive opportunity to explore and enjoy three different trial products of your choice, absolutely free! | 10μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $36.90 | |
| Ab095464-50μg | 50μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $99.90 | |
| Ab095464-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $169.90 | |
| Ab095464-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $999.90 |
mAb (BU63); Mouse anti Human CD86 Antibody; Flow; Unconjugated
| Product Name | CD86 Mouse mAb - Primary antibody, specific to CD86, Mouse IgG1 |
|---|---|
| Synonyms | Activation B7-2 antigen; B70; B7-2 antigen; B72; B7-2; B-lymphocyte activation antigen B7-2; BU63; CD28 antigen ligand 2; CD28LG2B7-2 antigen); CD86 antigen; CD86 molecule; CD86; CTLA-4 counter-receptor B7.2; FUN-1; LAB72; MGC34413; T-lymphocyte activatio |
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Azide Free, Lot by Lot |
| Host species | Mouse |
| Specificity | CD86 |
| Immunogen | ARH 77 (B lymphoblastoid cell line). |
| Positive Control | Flow: Human peripheral blood monocyte. |
| Conjugate | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™ |
| Isotype | Mouse IgG1 |
|---|---|
| SDS-PAGE | 150 kDa |
| Purification Method | Protein G purified |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at 2-8°C |
| Shipped In | Wet ice |
| Stability And Storage | Shipped at 4°C. Store at 4°C long term (12 months). Upon delivery aliquot. |
Anti-CD86 antibody (Ab095464) - Flow Cytometry
Flow Cytometry analysis of Raji cells labelling CD86 (red) with Anti-CD86 antibody (Ab095464) at 0.1 μg/mL for 1 hour at 4°C. AffiniPure Goat anti-Mouse IgG, Fcγ fragment specific (Alexa Fluor® 647) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, mouse IgG (Ab170221). Black - Unlabelled control, cells without incubation with primary antibody.
| Application | Notes |
|---|---|
| Flow | 1μg/100w cells |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0202986 | Certificate of Analysis | Mar 01, 2024 | Ab095464 |
| ZJ23F1201931 | Certificate of Analysis | Dec 06, 2023 | Ab095464 |
| ZJ23F1201932 | Certificate of Analysis | Dec 06, 2023 | Ab095464 |
| 1. Vicente Rabaneda EF, Herrero-Beaumont G, Castañeda S. (2013) Update on the use of abatacept for the treatment of rheumatoid arthritis.. Expert Rev Clin Immunol, 9 (7): (599-621). [PMID:23899231] |
| 2. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7.. J Exp Med, 174 (3): (561-9). [PMID:1714933] |
| 3. Engel, P P and 8 more authors.. (1994) The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.. Blood, (1): [PMID:7520767] |
| 4. Lanier, L L LL and 7 more authors.. (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:7527824] |
| 5. Jellis, C L CL and 6 more authors.. (1995) Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).. Immunogenetics, [PMID:7541777] |
| 6. Azuma, M M and 6 more authors.. (1993) B70 antigen is a second ligand for CTLA-4 and CD28.. Nature, (4): [PMID:7694153] |
| 7. Freeman, G J GJ and 7 more authors.. (1993) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.. Science (New York, N.Y.), (5): [PMID:7694363] |
| 8. Magistrelli, G G and 5 more authors.. (2001) Identification of an alternatively spliced variant of human CD86 mRNA.. Biochemical and biophysical research communications, (9): [PMID:11162656] |
| 9. Schwartz, J C JC, Zhang, X X, Fedorov, A A AA, Nathenson, S G SG and Almo, S C SC.. (2001) Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.. Nature, (29): [PMID:11279501] |
| 10. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ.. (2002) TTD: Therapeutic Target Database.. Nucleic acids research, (1): [PMID:11752352] |
| 11. Goto, Eiji E and 6 more authors.. (2003) c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity.. The Journal of biological chemistry, (25): [PMID:12582153] |
| 12. Zhang, Xuewu X, Schwartz, Jean-Claude D JC, Almo, Steven C SC and Nathenson, Stanley G SG.. (2003) Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.. Proceedings of the National Academy of Sciences of the United States of America, (4): [PMID:12606712] |
| 13. and Kremer, Joel M JM.. (2005) Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis.. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, [PMID:16357751] |
| 14. Hervey, Pauline S PS and Keam, Susan J SJ.. (2006) Abatacept.. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, [PMID:16573350] |
| 15. Muzny, Donna M DM and 113 more authors.. (2006) The DNA sequence, annotation and analysis of human chromosome 3.. Nature, (27): [PMID:16641997] |
| 16. Weyand, Cornelia M CM and Goronzy, Jörg J JJ.. (2006) T-cell-targeted therapies in rheumatoid arthritis.. Nature clinical practice. Rheumatology, [PMID:16932686] |
| 17. and Scheinfeld, Noah N.. (2006) Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.. The Journal of dermatological treatment, [PMID:16971318] |
| 18. Vincenti, Flavio F and Luggen, Michael M.. (2007) T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.. Annual review of medicine, [PMID:17020493] |
| 19. Nogid, Anna A and Pham, David Q DQ.. (2006) Role of abatacept in the management of rheumatoid arthritis.. Clinical therapeutics, [PMID:17212998] |
| 20. Reynolds, Jennifer J, Shojania, Kam K and Marra, Carlo A CA.. (2007) Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis.. Pharmacotherapy, [PMID:18041889] |
| 21. and Vincenti, Flavio F.. (2008) Costimulation blockade in autoimmunity and transplantation.. The Journal of allergy and clinical immunology, [PMID:18269922] |
| 22. Maxwell, Lara J LJ and Singh, Jasvinder A JA.. (2010) Abatacept for rheumatoid arthritis: a Cochrane systematic review.. The Journal of rheumatology, [PMID:20080922] |
| 23. Kleinpeter, Patricia and 20 more authors.. (2019) By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.. Journal of virology, (1): [PMID:30918073] |
